operates as a development stage company which develops biopharmaceuticals used for the treatment of cancer
Industry Biotechnology
A.I.dvisor tells us that PBYI and FHTX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PBYI and FHTX's prices will move in lockstep.
Ticker / NAME | Correlation To PBYI | 1D Price Change % | ||
---|---|---|---|---|
PBYI | 100% | -4.80% | ||
FHTX - PBYI | 31% Poorly correlated | -5.19% | ||
VIR - PBYI | 30% Poorly correlated | -5.81% | ||
VRCA - PBYI | 29% Poorly correlated | -7.23% | ||
NBTX - PBYI | 28% Poorly correlated | -12.17% | ||
EDIT - PBYI | 28% Poorly correlated | -6.68% | ||
More |
Ticker / NAME | Correlation To PBYI | 1D Price Change % |
---|---|---|
PBYI | 100% | -4.80% |
biotechnology theme (248 stocks) | 27% Poorly correlated | +5.56% |
drugs theme (265 stocks) | 26% Poorly correlated | +5.37% |
cancer theme (87 stocks) | 26% Poorly correlated | +0.89% |
biopharmaceuticals theme (52 stocks) | 25% Poorly correlated | +2.00% |
treatment theme (61 stocks) | 23% Poorly correlated | +0.91% |